Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06296342 · ClinicalTrials.gov registry record · NA
Message Framing and Policy Support for Front-of-package Labeling
A NA study of Diet, Healthy, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 4,107
- Enrollment target
- 1
- Study location
NCT06296342: Completed NA study of Diet, Healthy, sponsored by University of North Carolina, Chapel Hill.
NCT06296342 is a NA study of Diet, Healthy that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 4,107 participants, above the 422-participant average among 48 other Diet, Healthy trials with a reported enrollment target (873% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06296342, a NA study of Diet, Healthy, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 4,107 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to assess whether different message framing about front-of-package labeling policies elicits more policy support than the control (no framing) among Latino and limited English proficiency populations. The study also seeks to identify which message framing elicits the most policy support.
Primary Outcome
Policy support will be assessed with 1 item: "How much would you support or oppose this policy?" This item will be measured on a 4-point scale ranging from (1) "Strongly oppose this policy" to (4) "Strongly support this policy", where higher scores indicate higher support for the front-of-package labeling policy. The final outcome will be dichotomized so that 0=Oppose this policy and 1=Support this policy.
Conditions Studied
Interventions
- BEHAVIORAL Exposure to information framing message
- BEHAVIORAL Exposure to healthier choices framing message
- BEHAVIORAL Exposure to industry framing message
Study Locations (1)
North Carolina
- The University of North Carolina at Chapel Hill's Gillings School of Global Public Health - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,107 participants |
| Start Date | 2024-08-09 |
| Est. Completion | 2024-09-11 |
| Phase | NA |
What the finished NCT06296342 record still lists
NCT06296342 is an interventional study that assigns participants to a tested intervention. Its 4,107 participants enrollment target places it among the larger protocols in the corpus, above the 422-participant average among 48 other Diet, Healthy trials with a reported enrollment target (873% higher).
The record links to 1 condition, with Diet, Healthy appearing as the primary indexed condition, and to 3 interventions - of which Exposure to information framing message is the first listed.
NCT06296342 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT06296342 about?
NCT06296342 is a clinical study titled "Message Framing and Policy Support for Front-of-package Labeling". This study aims to assess whether different message framing about front-of-package labeling policies elicits more policy support than the control (no framing) among Latino and limited English proficiency populations. The study also seeks to identify which message framing elicits the most policy supp...
What is the current status of trial NCT06296342?
This trial is currently completed. It is a NA study. The enrollment target is 4,107 participants. The study started on 2024-08-09. Estimated completion is 2024-09-11.
What conditions does trial NCT06296342 study?
This clinical trial studies the following conditions: Diet, Healthy.
What interventions are being tested in trial NCT06296342?
The interventions under investigation include: Exposure to information framing message (BEHAVIORAL), Exposure to healthier choices framing message (BEHAVIORAL), Exposure to industry framing message (BEHAVIORAL).
Who is sponsoring clinical trial NCT06296342?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06296342 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diet, Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06296342's enrollment target sits among peer trials
4,107 1st of 48 higher than 48 of 48 other Diet, Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diet, Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sip and Snack Better (SSB) Study: Improving Added Sugar in Adolescents
RECRUITING · NA
-
Delivering HOPE (Helping Women Optimize Prenatal Equity)
RECRUITING · NA
-
Strong Families Start at Home/Familias Fuertes Comienzan en Casa
RECRUITING · NA
-
Dietary Intervention to Improve Kidney Transplant Outcomes
RECRUITING · NA
-
Medically Tailored Meals for Cardiovascular Health
RECRUITING · NA
-
Whole Foods for Teens: A Pilot Dietary Intervention to Reduce Body Adiposity in Adolescents With Obesity
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03388606 · 4,100 participants
Characterization and Treatment of Adolescent Depression
- NCT06593353 · 4,165 participants · NA
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
- NCT02693535 · 4,200 participants · Phase 2
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- NCT05969028 · 4,200 participants · NA
First Responder Airway & Compression Rate Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI